Effects of adaptive immune cell therapy on the immune cell profile in patients with advanced gastric cancer.
Miyabi MiuraEishiro MizukoshiTomomi HashibaMasaaki KitaharaTomoharu MiyashitaTakafumi MochizukiShigenori GotoTakashi KamigakiRishu TakimotoTaro YamashitaYoshio SakaiTatsuya YamashitaMasao HondaShuichi KanekoPublished in: Cancer medicine (2020)
Our results suggested that αβT-cell therapy changes the host's immune cell profile, and an increase in PD-1+ effector Tregs may help improve prognosis.